March 10, 2025 11:37 AM EDT
R&D
Pharma

#AAD25: What you need to know from Am­gen, Bris­tol My­ers, J&J and more

Ayisha Sharma

News Reporter

At this year’s Amer­i­can Acad­e­my of Der­ma­tol­ogy an­nu­al meet­ing, com­pa­nies like Am­gen, Bris­tol My­ers Squibb and Alu­mis took the stage to re­port the lat­est on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

New Flag­ship start­up aims to trail­blaze ‘AI sci­ence fac­to­ries’

Ex­clu­sive: FDA blocks drug and de­vice re­view­ers from tak­ing HH­S' buy­out of­fer

Beam shares promis­ing first clin­i­cal da­ta on gene edit­ing treat­ment for a lung and liv­er dis­ease 

Emer­gent sells once-trou­bled man­u­fac­tur­ing site to In­di­an CD­MO

BioN­Tech's shares dip af­ter post­ing luke­warm rev­enue guid­ance

sponsored

Obe­si­ty drug de­vel­op­ment—still room to grow

A service from the Financial Times